Temasek-backed Indian online drugstore PharmEasy targets $9b IPO valuation

Temasek-backed Indian online drugstore PharmEasy targets $9b IPO valuation

Photo: Pixabay

Online drugstore PharmEasy, which bought diagnostic chain Thyrocare in June, aims to raise a billion dollars at a valuation of $9 billion in its initial public offering later this year, two people directly aware of the company’s plans said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter